Movement Alert|DexCom Falls 5.06% in Regular Trading, Trading at $70.91

Market Focus
Jul 23

On July 22, DexCom fell 5.06% in regular trading, trading at $70.91 USD/share, with Turnover of $147 million.

Within the Health Care Equipment sector where DexCom belongs, the overall sector performance was weak. Among individual stocks, Intuitive Surgical down 2.45%, Abbott Laboratories up 0.49%, Stryker down 1.37%, Boston Scientific down 0.94%, Edwards Lifesciences down 0.6%.

DexCom is a medical device company focused on the design, development, and commercialization of continuous glucose monitoring systems. The company is scheduled to release its Q2 earnings on July 30, with an expected EPS of $0.61.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10